Novel delta opioid receptor agonists with oxazatricyclodecane structure. - Wikidata - awgldk - TriplyDB

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

http://www.wikidata.org/entity/Q33636151

about

New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.

P2860

Q41181255-F7907EF4-27FD-41DD-8735-B470EE182612

P2860

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

http://www.wikidata.org/entity/Q33636151

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@ast

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@en

type

label

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@ast

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@en

prefLabel

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@ast

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@en

P1433

Q33636151-D5EF7B78-30B2-4B86-A0E4-F8B3EC26C333

P1476

Q33636151-DE4E1524-C0A4-49E1-B004-188EA8880978

P2093

Q33636151-03B234F6-C562-4D70-ACB7-F6D99A02A46F

Q33636151-46BEDD1D-29FD-4035-B369-AE8548C64454

Q33636151-685A3C67-3281-46CE-AF2A-CF25422D9041

Q33636151-788B470F-097D-4C15-B814-5B635699C78B

Q33636151-7DF27B01-86BA-438A-967E-524BBC9FC97B

Q33636151-9A348A30-398C-453D-88DC-6ED32545DAB5

Q33636151-9EA18D37-0938-4A59-8392-05DF1808C2DE

Q33636151-A3652172-B117-4E6A-B519-C8793EBD25EE

Q33636151-E09DEF02-6A50-4D12-B14A-BCFE6E575D4F

Q33636151-E5A89F21-8BCF-40E8-A0B1-DD3CBA910F57

P2860

Q33636151-12DE12C2-0E7B-41E0-9CA7-1E635A177D75

Q33636151-32527B60-CE46-443C-A30F-A6AFADBBAF44

Q33636151-33CA225A-1A0E-4DED-815F-2823C3E25EFC

Q33636151-349DACD9-486E-4E6C-9D22-884157AD78B3

Q33636151-36D03379-7B39-49AA-B4C6-325D551A8FCA

Q33636151-3FF8FCA9-6F7B-4B08-AB42-379410F73793

Q33636151-50AF0FD9-8ADF-497A-BEA6-B344A56E3D0F

Q33636151-5347378E-FCE7-43EA-A2A6-DE916EFDFB1E

Q33636151-822132B2-21B5-4CBB-B19C-1AD9D223783E

Q33636151-8F38258A-F461-4E72-967D-27DBE0D426EB

P304

Q33636151-F9B045A7-4DBE-4FE0-8BCE-133689AF8F23

P31

Q33636151-CFB10F73-F53F-456F-AF3D-55F3A375E693

P356

Q33636151-42439C30-1886-48E0-A1E6-6F5251CFA558

P433

Q33636151-5C839C55-1F25-405A-9398-E203A8C0BD75

P478

Q33636151-74635105-017E-433B-A135-AD300D2BC80B

P50

Q33636151-842B6F7B-39AD-45E7-BF1F-8A7E591695CB

P577

Q33636151-59329DF1-79D7-450E-9DBF-C7048F2D864A

P698

Q33636151-2CE6E9D1-F6D2-4ED9-9A2D-0D13AFC928CC

P932

Q33636151-CD76742F-28DC-4002-B4F3-16F382E6A6D4

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Novel delta opioid receptor agonists with oxazatricyclodecane structure.

@en

P2093

Akinobu Yokoyama

http://www.w3.org/2001/XMLSchema#string

Akiyoshi Saitoh

http://www.w3.org/2001/XMLSchema#string

Eriko Nakata

http://www.w3.org/2001/XMLSchema#string

Hideaki Fujii

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nagase

http://www.w3.org/2001/XMLSchema#string

Kohei Hayashida

http://www.w3.org/2001/XMLSchema#string

Mitsuhiko Yamada

http://www.w3.org/2001/XMLSchema#string

Shigeto Hirayama

http://www.w3.org/2001/XMLSchema#string

Toru Nemoto

http://www.w3.org/2001/XMLSchema#string

Yasuhito Uezono

http://www.w3.org/2001/XMLSchema#string

P2860

The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors

In vivo delta opioid receptor internalization controls behavioral effects of agonists

Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist

Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)

Preclinical pharmacology of AZD2327: a highly selective agonist of the δ-opioid receptor

Design of peptidomimetic delta opioid receptor antagonists using the message-address concept

The pharmacological profile of delta opioid receptor ligands, (+) and (-) TAN-67 on pain modulation.

Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.

A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.

Rational drug design and synthesis of a highly selective nonpeptide delta-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl- 1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67).

P304

368-372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML400491K

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24900842

http://www.w3.org/2001/XMLSchema#string

P932

4027615

http://www.w3.org/2001/XMLSchema#string